Cancer-related fatigue (CRF) is a recognised clinical syndrome distinct from ordinary tiredness. It does not resolve with rest alone and can persist for months or years after treatment. It is thought to involve inflammatory pathways, hormonal disruption, anaemia, and psychological factors. It can be assessed and managed — it is not something patients simply have to accept.

Some supplements are appropriate and potentially beneficial; others can interfere with treatment effectiveness or interact with medications. The evidence varies considerably by supplement and cancer type. We review your specific treatment history and current supplement use to give you a grounded, individualised answer — not a generic yes or no.

Follow-up care after cancer treatment should include scheduled clinical review, relevant blood markers or tumour markers depending on cancer type, and periodic imaging where indicated. The frequency and content of follow-up varies by cancer type, stage, and treatment received. In this consultation we review your current plan and compare it against standard-of-care guidelines so you know whether you are being appropriately monitored.

You do not need to wait. Patients currently in active treatment benefit from side effect management support, and patients who finished treatment months or even years ago can still benefit from addressing persistent issues. There is no wrong time to seek clarity on your recovery.